HSF (SV40) Cells

Unit

3 x 10^6 cells/ml

Cell Type

Immortalized Cells

Tissue Type

Human cells

Organism

Human

Donor History
Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1 to 3 × 10⁴ cells/cm². Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/HSF-SV40-Cells/305338

SKU: 305338 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The HSF(SV40) immortalized cell line refers to cells that have been genetically modified to express the Simian Virus 40 (SV40) large T-antigen (T-Ag), which facilitates cellular immortalization. SV40 T-Ag is a potent oncoprotein that interacts with critical tumor suppressor proteins, such as p53 and retinoblastoma protein (Rb), leading to the inactivation of their tumor-suppressive functions. This interaction disrupts normal cell cycle control mechanisms, allowing cells to bypass senescence and proliferate indefinitely.
Due to their immortalized nature and the critical involvement of SV40 T-Ag in their transformation, HSF(SV40) cells are widely used in cancer research, particularly in studies related to viral oncogenesis, cell cycle regulation, and therapeutic interventions targeting molecular chaperones and tumor suppressor pathways. Their use provides valuable insights into the interplay between viral oncoproteins and host cell regulatory networks, paving the way for the development of targeted cancer therapies.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.